The combination of PD-1 and PD-L1, a ligand expressed on the tumor surface, can attenuate the activity of PD-1+ cells, inhibit their proliferation, and induce their apoptosis, thereby mediating tumor immune escape. Here, CD274 is linked to neoplasm.